Viewing Study NCT02420132


Ignite Creation Date: 2025-12-24 @ 9:43 PM
Ignite Modification Date: 2026-02-22 @ 9:04 AM
Study NCT ID: NCT02420132
Status: COMPLETED
Last Update Posted: 2019-06-10
First Post: 2015-04-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study to Evaluate Home Vision Testing in Participants Who Receive Ranibizumab (Lucentis®)
Sponsor: Hoffmann-La Roche
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2015-04-20
Start Date Type: ACTUAL
Primary Completion Date: 2016-08-25
Primary Completion Date Type: ACTUAL
Completion Date: 2016-08-25
Completion Date Type: ACTUAL
First Submit Date: 2015-04-14
First Submit QC Date: None
Study First Post Date: 2015-04-17
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2019-06-06
Last Update Post Date: 2019-06-10
Last Update Post Date Type: ACTUAL